Oksidatif Stres Kaynaklı Hastalıklarda Yeni Nesil Antioksidan Terapiler ve İlaç Hedefleme Yöntemleri
Özet
Bu kitap bölümü, oksidatif stresin nörodejeneratif, kardiyovasküler, metabolik ve otoimmün hastalıkların patofizyolojisindeki rolünü detaylı bir şekilde incelemektedir. Bölüm, öncelikle reaktif oksijen türleri (ROS) ve bu türlerin lipitler, proteinler ve DNA üzerindeki zarar verici etkileri gibi temel biyolojik mekanizmalara odaklanmaktadır.
Bu temel bilgiler ışığında, bölüm mitokondri hedefli antioksidanlar, nano-antioksidanlar ve eksozom bazlı terapiler gibi ileri düzey tedavi yaklaşımlarını ele almaktadır. Geleneksel antioksidan tedavilere kıyasla, bu yeni nesil stratejiler daha yüksek spesifiklik, geliştirilmiş biyoyararlanım ve hedefe yönelik dağıtım mekanizmaları sunarak terapötik etkinliği artırmaktadır.
Bölüm ayrıca, ilaç geliştirme süreçleri, farmasötik yenilikler ve nanoteknolojiye dayalı terapötik yaklaşımlar üzerine odaklanarak, oksidatif stres kaynaklı hastalıkların tedavisinde yeni stratejilerin nasıl şekillendiğini analiz etmektedir. Son olarak, bu yenilikçi terapilerin klinik uygulamalara entegrasyonu için güvenlik, etkinlik ve bireyselleştirilmiş tedavi yaklaşımlarının daha kapsamlı araştırılması gerektiği vurgulanmaktadır.
This book chapter, provides an in-depth analysis of oxidative stress as a key contributor to the pathophysiology of various chronic diseases, including neurodegenerative, cardiovascular, metabolic, and autoimmune disorders. The chapter begins with a discussion on the biological mechanisms of oxidative stress, emphasizing the role of reactive oxygen species (ROS) and their impact on cellular components such as lipids, proteins, and DNA.
Following this foundation, the chapter explores advanced therapeutic strategies aimed at mitigating oxidative damage. These include mitochondria-targeted antioxidants, nano-antioxidants, and exosome-based therapies, which have demonstrated promising results in preclinical and clinical studies. Compared to traditional antioxidant approaches, these new-generation therapies offer higher specificity, improved bioavailability, and targeted delivery mechanisms that enhance therapeutic efficacy.
The chapter also delves into pharmaceutical interventions, discussing emerging drug development strategies and nanotechnology-driven innovations. Finally, it underscores the need for further research to optimize these novel therapies for widespread clinical application, with a focus on safety, effectiveness, and personalized treatment approaches.
Referanslar
Sies, H., Oxidative stress: a concept in redox biology and medicine. Redox Biol, 2015. 4: p. 180-3.
Liguori, I., et al., Oxidative stress, aging, and diseases. Clin Interv Aging, 2018. 13: p. 757-772.
Betteridge, D.J., What is oxidative stress? Metabolism, 2000. 49(2 Suppl 1): p. 3-8.
Halliwell, B. and J.M.C. Gutteridge, Free Radicals in Biology and Medicine. 2015: Oxford University Press.
Valko, M., et al., Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol, 2007. 39(1): p. 44-84.
L'Abbate, A. and F. Ursini. The Role of Oxygen Radicals in Cardiovascular Diseases. in Springer Netherlands. 1988.
Jie, H., et al., Interplay between energy metabolism and NADPH oxidase-mediated pathophysiology in cardiovascular diseases. Front Pharmacol, 2024. 15: p. 1503824.
Olas, B., et al., Hippophae rhamnoides L. Fruits Reduce the Oxidative Stress in Human Blood Platelets and Plasma. Oxid Med Cell Longev, 2016. 2016: p. 4692486.
Sendão, R.M.S., et al., Visible-light-driven photocatalytic degradation of organic dyes using a TiO2 and waste-based carbon dots nanocomposite. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 2025. 713: p. 136475.
Finazzi, M., et al., Beneficial Effects of In Vitro Reconstructed Human Gut Microbiota by Ginseng Extract Fermentation on Intestinal Cell Lines. Microorganisms, 2025. 13(1): p. 192.
Guo, X., et al., MnGA with multiple enzyme-like properties for acute wound healing by reducing oxidative stress and modulating signaling pathways. Materials Today Bio, 2025. 30: p. 101435.
Yıldız, F., T.W. LeBaron, and D. Alwazeer, A comprehensive review of molecular hydrogen as a novel nutrition therapy in relieving oxidative stress and diseases: Mechanisms and perspectives. Biochemistry and Biophysics Reports, 2025. 41: p. 101933.
Simões e Silva, A.C., Oxidative Stress in Renal Health. Antioxidants, 2025. 14(2): p. 144.
Chen, M.W., et al., Transition-State-Dependent Spontaneous Generation of Reactive Oxygen Species by Aβ Assemblies Encodes a Self-Regulated Positive Feedback Loop for Aggregate Formation. Journal of the American Chemical Society, 2025.
Verderi, L., et al., Cytotoxic ROS-Consuming Mn(III) Synzymes: Structural Influence on Their Mechanism of Action. International Journal of Molecular Sciences, 2025. 26(1): p. 150.
Pal, C., Design and synthesis of a Thymol dimer with antioxidant properties for the prevention of iron-mediated protein degradation. Journal of the Indian Chemical Society, 2025. 102(1): p. 101516.
Zikaki, K., et al., “Villains” Turning Good: Antimycin A and Rotenone, Mitochondrial Respiratory Chain Inhibitors, Protect H9c2 Cardiac Cells Against Insults Triggering the Intrinsic Apoptotic Pathway. International Journal of Molecular Sciences, 2025. 26(6): p. 2435.
Qhabibi, F., Algal Peptides for Future Food: Key Players and Multifaceted Agents in the Fight Against Cardiometabolic Syndrome. Journal of Agriculture and Food Research, 2025. 20: p. 101786.
Al-Khikani, F., From Tradition to Therapy: Medicinal Plants as a Promising Approach to Atherosclerosis. 2025.
Berdowska, I., M. Matusiewicz, and I. Fecka, A Comprehensive Review of Metabolic Dysfunction-Associated Steatotic Liver Disease: Its Mechanistic Development Focusing on Methylglyoxal and Counterbalancing Treatment Strategies. International Journal of Molecular Sciences, 2025. 26(6): p. 2394.
Zavvari Oskuye, Z., et al., Klotho in age-related cardiovascular diseases: Insights into mitochondrial dysfunction and cell death. IJC Heart & Vasculature, 2025. 57: p. 101629.
Trube, J., et al., Colchicine therapy in cardiovascular medicine: A literature review. American Heart Journal Plus: Cardiology Research and Practice, 2025. 52: p. 100525.
Singh, S.R., et al., A study on the antioxidant, cytotoxicity, and coagulation potential of carbon quantum dots derived from the leaves of Lagerstroemia speciosa. Hybrid Advances, 2025. 10: p. 100430.
Zhao, Y., et al., The miR-21-5p/DUSP8/MAPK signaling pathway mediates inflammation and apoptosis in vascular endothelial cells induced by intermittent hypoxia and contributes to the protective effects of N-acetylcysteine. European Journal of Pharmacology, 2025: p. 177462.
Pislyagin, E.A., et al., Neuroprotective Activity of Oligomeric Stilbenes from Alpha Grape Stems in In Vitro Models of Parkinson’s Disease. International Journal of Molecular Sciences, 2025. 26(6): p. 2411.
Russo, A., et al., Emerging Ferroptosis Involvement in Amyotrophic Lateral Sclerosis Pathogenesis: Neuroprotective Activity of Polyphenols. Molecules, 2025. 30(6): p. 1211.
Bouyahya, A., et al., Unlocking the natural chemical sources, nutritional properties, biological effects, and molecular actions of Ajoene. Journal of Functional Foods, 2025. 127: p. 106714.
Dai, Y., et al., JAK/STAT signaling as a key regulator of ferroptosis: mechanisms and therapeutic potentials in cancer and diseases. Cancer Cell International, 2025. 25(1): p. 83.
Li, S., et al., FOXO6: A Unique Transcription Factor in Disease Regulation and Therapeutic Potential. Pharmacological Research, 2025: p. 107691.
Anandan, A., et al., Shikonin Ameliorates Rotenone-Induced Neurotoxicity Through Inhibition of Apoptosis via IGF-1R/PI3K/AKT Pathway in a Parkinson’s Disease-Associated SH-SY5Y Cell Model. Molecular Neurobiology, 2025.
Anjum, A., et al., NeuroAid™-II (MLC901) provides neuroprotection and enhances neuronal cell survival against kainic acid-induced excitotoxicity in vitro by activating the PI3K/AKT pathway. Future Journal of Pharmaceutical Sciences, 2025. 11(1): p. 31.
Boukholda, K., et al., Toxicological Alterations Induced by Subacute Exposure of Cobalt Oxide Nanoparticles in Aged Rats: Behavioral, Biochemical, Molecular, and Histopathological Evidence. Biological Trace Element Research, 2025.
Kasrineh, F.A., et al., Prenatal irisin is inversely related to the term placental telomere length. BMC Research Notes, 2025. 18(1): p. 102.
He, L., et al., Metabolic profile of procyanidin A2 by human intestinal microbiota and their antioxidant and hypolipidemic potential in HepG2 cells. European Journal of Nutrition, 2025. 64(3): p. 113.
Hao, D.-D., et al., Acteoside inhibits hepatic lipid accumulation and oxidative stress in type 2 diabetic mice via the Nrf2/HO-1 Pathway. Journal of Toxicology and Environmental Health, Part A: p. 1-10.
Zhong, Y.-l., et al., Mitochondrial dynamics and metabolism in macrophages for cardiovascular disease: A review. Phytomedicine, 2025. 140: p. 156620.
Chen, Y., et al., In silico prospecting of ADH activating peptides from Pacific oyster (Crassostrea gigas) and protective effect on ethanol-induced damage in HepG2 cells. Food Chemistry, 2025: p. 143777.
Liu, C.-J., L.-K. Wang, and F.-M. Tsai, The Application and Molecular Mechanisms of Mitochondria-Targeted Antioxidants in Chemotherapy-Induced Cardiac Injury. Current Issues in Molecular Biology, 2025. 47(3): p. 176.
Chou, H.-L., et al., Aniline TFPA enhances camptothecin-induced anti-NSCLC by modulating oxidative stress and impairing autophagy. Cancer Cell International, 2025. 25(1): p. 81.
Zhong, L., et al., Dopant-Regulated Piezocatalysts Evoke Sonopiezoelectric and Enzymatic PANoptosis for Synergistic Cancer Therapy. Advanced Science. n/a(n/a): p. 2500406.
Morelli, E., et al., Targeting Acetyl-CoA Carboxylase Suppresses De Novo Lipogenesis and Tumor Cell Growth in Multiple Myeloma. Clinical Cancer Research, 2025.
Fajkiel-Madajczyk, A., et al., Evaluating the Role of Coenzyme Q10 in Migraine Therapy—A Narrative Review. Antioxidants, 2025. 14(3): p. 318.
Newman, P.P., et al., Polysaccharides with Arabinose: Key Players in Reducing Chronic Inflammation and Enhancing Immune Health in Aging. Molecules, 2025. 30(5): p. 1178.
Kelemen, K. and K. Orban-Kis, Marked differences in the effects of levetiracetam and its analogue brivaracetam on microglial, astrocytic, and neuronal density in the rat model of kainic acid- induced temporal lobe epilepsy. Frontiers in Pharmacology, 2025.
Chen, Z., et al., Therapeutic Efficacy of Xuebijing Injection in Treating Severe Acute Pancreatitis and its Mechanisms of Action: A Comprehensive Survey. Phytomedicine, 2025: p. 156629.
Lin, H.-H., et al., Desmodium caudatum (Thunb.) DC. Extract Attenuates Hyperuricemia-Induced Renal Fibrosis via Modulating TGF-β1 Pathway and Uric Acid Transporters: Evidence from In Vitro and In Vivo Studies. Journal of Ethnopharmacology, 2025: p. 119609.
Liu, M., et al., T-2 toxin-induced splenic injury by disrupting the gut microbiota–spleen axis via promoting IL-6/JAK/STAT1 signaling-mediated inflammation and apoptosis and its mitigation by elemental nano-selenium. Archives of Toxicology, 2025.
Abdelbagi, O., et al., Ameliorative Effect of N-Acetylcysteine Against 5-Fluorouracil-Induced Cardiotoxicity via Targeting TLR4/NF-κB and Nrf2/HO-1 Pathways. Medicina, 2025. 61(2): p. 335.
Wang, X., et al., Effect and mechanism of Dichloroacetate in the treatment of stroke and the resolution strategy for side effect. European Journal of Medical Research, 2025. 30(1): p. 148.
Matsui, T., et al., Empagliflozin ameliorates renal and metabolic derangements in obese type 2 diabetic mice by blocking advanced glycation end product–receptor axis. Molecular Medicine, 2025. 31(1): p. 88.
Gitaswari, I., et al., Systemic allopurinol administration reduces malondialdehyde, interleukin 6, tumor necrosis factor α, and increases vascular endothelial growth factor in random flap Wistar rats exposed to nicotine. Acta Chir Plast, 2024. 66(2): p. 60-66.
Zhang, W., et al., Spinal AT1R contributes to neuroinflammation and neuropathic pain via NOX2-dependent redox signaling in microglia. Free Radical Biology and Medicine, 2025. 227: p. 143-156.
Batinac, T., et al., Endothelial Dysfunction and Cardiovascular Disease: Hyperbaric Oxygen Therapy as an Emerging Therapeutic Modality? Journal of Cardiovascular Development and Disease, 2024. 11(12): p. 408.
Zicarelli, M., et al., Comprehensive Insights into Sarcopenia in Dialysis Patients: Mechanisms, Assessment, and Therapeutic Approaches. Medicina, 2025. 61(3): p. 449.
Nethengwe, M., et al., Androstachys johnsonii Prain aqueous leaf extract attenuates oxidative stress in hyperglycaemic-induced spermatozoa: An in vitro study. Clinical Traditional Medicine and Pharmacology, 2025: p. 200204.
Yang, Y., et al., Mitochondria as therapeutic targets for Natural Products in the treatment of Cardiovascular Diseases. Journal of Ethnopharmacology, 2025: p. 119588.
Ferreira, F.C., et al., Assisted Reproduction Technologies (ART): Impact of Mitochondrial (Dys)function and Antioxidant Therapy. Animals, 2025. 15(3): p. 289.
Karakozova, M.V., A.I. Sorochkina, and P.A. Nazarov, Two-faced Janus SkQ1/SkQR1: patterns and molecular volume threshold for substrate recognition by the AcrAB-TolC pump. Frontiers in Pharmacology, 2025. 16.
Ciubotaru, A.D., et al., Behavioral and Biochemical Insights into the Therapeutic Potential of Mitocurcumin in a Zebrafish–Pentylenetetrazole (PTZ) Epilepsy Model. Pharmaceuticals, 2025. 18(3): p. 382.
Samrot, A.V., et al., Nanoparticles, a Double-Edged Sword with Oxidant as Well as Antioxidant Properties—A Review. Oxygen, 2022. 2(4): p. 591-604.
Losada-Barreiro, S., et al., Biochemistry of Antioxidants: Mechanisms and Pharmaceutical Applications. Biomedicines, 2022. 10(12): p. 3051.
Mirzaei, M., et al., Employing Supervised Algorithms for the Prediction of Nanomaterial’s Antioxidant Efficiency. International Journal of Molecular Sciences, 2023. 24(3): p. 2792.
Akanchise, T. and A. Angelova, Potential of Nano-Antioxidants and Nanomedicine for Recovery from Neurological Disorders Linked to Long COVID Syndrome. Antioxidants, 2023. 12(2): p. 393.
Ba, X., et al., Recent Advances in Nanomaterials for the Treatment of Acute Kidney Injury. ACS Applied Materials & Interfaces, 2024. 16(10): p. 12117-12148.
Ai, Y., et al., Nanoplatform-Based Reactive Oxygen Species Scavengers for Therapy of Ischemia-Reperfusion Injury. Advanced Therapeutics, 2022. 5(11): p. 2200066.
Berehu, H.M., S. Anupriya, and S. Patnaik, Nanotechnology-Based Therapeutics in ROS-Induced Cancer, in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects, S. Chakraborti, Editor. 2021, Springer Nature Singapore: Singapore. p. 1-20.
Ghotaslou, A., et al., Harnessing HEK293 cell-derived exosomes for hsa-miR-365a-3p delivery: Potential application in hepatocellular carcinoma therapy. Heliyon, 2024. 10(8).
Wei, B., et al., Mesenchymal Stem Cell-Derived Exosomes: A Promising Therapeutic Strategy for Age-Related Diseases. Cell Proliferation. n/a(n/a): p. e13795.
Ma, Y., et al., A cascade synergetic strategy induced by photothermal effect based on platelet exosome nanoparticles for tumor therapy. Biomaterials, 2022. 282: p. 121384.
Tienda-Vázquez, M.A., et al., Exosomes: A Promising Strategy for Repair, Regeneration and Treatment of Skin Disorders. Cells, 2023. 12(12): p. 1625.
Liu, J., Research advances in the understanding of how exosomes regulate ferroptosis in cancer. Clinical and Translational Oncology, 2023. 25(7): p. 1906-1915.
Janockova, J., et al., New therapeutic approaches of mesenchymal stem cells-derived exosomes. Journal of Biomedical Science, 2021. 28(1): p. 39.
Cai, Y., et al., Therapeutic applications of adipose cell-free derivatives: a review. Stem Cell Research & Therapy, 2020. 11(1): p. 312.
